-
Inflammation in the vascular wall is important in atherosclerosis and the blockage of the
artery. The peripheral benzodiazepine receptor is involved in inflammation and in this
protocol we will attempt to take pictures, using PET camera, of inflammation in patients
with atherosclerosis and compare those of healthy people.
Location: National Institutes of Health Clinical Center, ...
Status: Completed
» Read more
-
To study the anti-inflammatory effects of marine omega-3 fatty acids, also known as n-3
polyunsaturated fatty acids (PUFA), we propose a randomized, double-blinded, prospective,
single-center trial to examine the effect of supplementary n-3 PUFA on serum high
sensitivity (hs) CRP levels.
Inclusion Criteria Age > 18 hs CRP >3mg/L and <10 mg/L
Exclusion Criteria
...
Location: Cleveland Clinic Willoughby Hills Family Health...
Status: Terminated
» Read more
-
Giant cell arteritis (GCA), also known as temporal arteritis, is a disease that usually only
occurs in older adults. GCA causes inflammation of blood vessels, or vasculitis. In order to
properly treat this disease, it is critical that the level of disease activity can be
determined over the course of the disease. The purpose of this study is to determine new
biological m...
Location: The Johns Hopkins Vasculitis Center
Status: Recruiting
» Read more
-
Cortico-dependence is frequent in giant cell arteritis patients, and no drugs has proved its
ability to prevent corticodependence. Hydrocychloroquine is a well tolerated
immunomodulatory drug that may have a corticosteroid sparing potential according to
immuno-pharmacological and clinical data. We have designed a multcentric double blind versus
placebo randomized control...
Location: Hospital
Status: Terminated
» Read more
-
Hypothesis: In giant cell arteritis (GCA), a short initial treatment with anti-TNF may allow
a faster decrease of steroids dosage and therefore avoid some of the adverse events of
steroids.
Location: Hôpital Bicêtre
Status: Active, not recruiting
» Read more
-
Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are diseases that cause swelling
of the arteries in the head, neck, upper body, and arms. TAK specifically affects the aorta,
the largest blood vessel in the body, and its branches. Therapies are available to improve
the symptoms of GCA and TAK, but relapse often occurs, and better treatments are needed.
Abatacept...
Location: Johns Hopkins Medical Center
Status: Recruiting
» Read more
-
Vasculitis is group of diseases where inflammation of blood vessels is the common feature.
Patients typically present with fever, fatigue, weakness and muscle and joint aches. These
symptoms are very common among many different diseases, not just vasculitis. A clustering
of other symptoms, physical examination findings, blood tests, radiology and biopsy help
make the d...
Location: Rigshospitalet
Status: Not yet recruiting
» Read more
-
Giant Cell Arteritis (GCA) causes inflammation and narrowing of blood vessels and can cause
blindness in one third of patients. It is important that a prompt, accurate diagnosis of GCA
is made and treatment given as steroids for two or more years. Currently there is no 100%
accurate test for GCA. Patients usually have new headache and scalp tenderness, typically
with an ...
Location: John Radcliffe Hospital
Status: Recruiting
» Read more
-
The factors underlying the large interindividual variability in response to glucocorticoids
in Giant Cell Arteritis are poorly understood. The investigators hypothesize that a part of
this variability is related to pharmacokinetic factors determined by genetic polymorphism:
hepatic clearance involving cytochromes P450 of the subfamily 3A (CYP3A) and drug efflux
leukocyte...
Location: CHU de CAEN
Status: Recruiting
» Read more